Smith Chas P & Associates Pa Cpas / MRK
Smith Chas P & Associates Pa Cpas’s Merck & Co Inc Position
Does Smith Chas P & Associates Pa Cpas own Merck & Co Inc (MRK)? Yes — 367.5K shares worth $44M (+2.40% of its 13F portfolio) as of Q1 2026, down from 370.9K shares the prior filed quarter.
Position Value
$44M
Q1 2026
Shares
367.5K
% of Portfolio
+2.40%
Quarters Held
30
currently held
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 367.5K | $44M | +2.40% |
| Q4 2025 | 370.9K | $39M | +2.05% |
| Q3 2025 | 228.5K | $19M | +1.66% |
| Q2 2025 | 355.2K | $28M | +1.58% |
| Q1 2025 | 341.2K | $31M | +1.78% |
| Q4 2024 | 330.0K | $33M | +1.89% |
| Q3 2024 | 331.6K | $38M | +2.12% |
| Q2 2024 | 335.3K | $42M | +2.46% |
| Q1 2024 | 335.1K | $44M | +2.67% |
| Q4 2023 | 333.7K | $36,385 | +2.40% |
| Q3 2023 | 329.3K | $33,904 | +2.47% |
| Q2 2023 | 336.5K | $38,823 | +2.49% |
| Q1 2023 | 330.4K | $35,155 | +2.39% |
| Q4 2022 | 360.3K | $39,973 | +2.84% |
| Q3 2022 | 362.7K | $31M | +2.65% |
| Q2 2022 | 357.8K | $33M | +2.35% |
| Q1 2022 | 356.0K | $29M | +2.21% |
| Q4 2021 | 350.0K | $27M | +1.83% |
| Q3 2021 | 342.5K | $26M | +1.93% |
| Q2 2021 | 324.1K | $25M | +1.96% |
| Q1 2021 | 312.9K | $24M | +2.26% |
| Q4 2020 | 296.6K | $24M | +2.44% |
| Q3 2020 | 291.4K | $24M | +2.72% |
| Q2 2020 | 292.0K | $23M | +2.75% |
| Q1 2020 | 294.6K | $23M | +3.13% |
| Q4 2019 | 292.1K | $27M | +2.88% |
| Q3 2019 | 298.0K | $25M | +2.89% |
| Q2 2019 | 306.6K | $26M | +3.02% |
| Q1 2019 | 316.6K | $26M | +3.23% |
| Q4 2018 | 333.8K | $26M | +3.46% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Smith Chas P & Associates Pa Cpas’s full portfolio or all institutional holders of MRK.